Category Archives: Harvard

Single-pill combo regimens for HIV

July 28, 2014- Interviewed by Steven E. Greer, MD Rajesh Tim Gandhi, MD of the Massachusetts General Hospital discusses the NEJM review paper

Posted in - NEJM, Harvard, Infectious disease | Leave a comment

NEJM letter casts doubt on original Gawande checklist paper

June 11, 2014- By Steven E. Greer, MD When the recent Canadian studied published in the NEJM failed to show any benefit from

Posted in - Policy, CMS, General surgery, Harvard | Leave a comment

Harvard professors feel the impact in their pocketbooks of the ACA law that they helped pass

Update January 5, 2014- This is now being reported in the New York Times, two-months after our reporting.

Posted in - Opinion, CMS, Harvard | Leave a comment

Reasons for permanent slowdowns in healthcare spending growth

May 17, 2013- Interviewed by Steven E. Greer, MD Since 2010,

Posted in CMS, Harvard | Leave a comment

How Boston medical centers prepare for unconventional weapon attacks

May 3, 2013- Interviewed by Steven E. Greer, MD Paul Biddinger, MD, Medical Director for Emergency Preparedness, Massachusetts General

Posted in - Policy, Boston University, CDC, Congress, Emergency medicine, Harvard, Trauma Surgery | Leave a comment

How Boston medical centers prepare for unconventional weapon attacks

May 3, 2013- Interviewed by Steven E. Greer, MD

Posted in - Policy, Boston University, Emergency medicine, Harvard, Trauma Surgery | Leave a comment

Questionable comments by Atul Gawande after the Boston Marathon bombings

April 20, 2013 By Steven E. Greer, MD Only two days after the April 15th Boston Marathon terrorist bombings, Harvard surgeon Atul

Posted in Harvard, Trauma Surgery | Leave a comment

The Damon Runyon Cancer Research Foundation panel

March 8, 2013  By Steven E. Greer, MD We interviewed three of the oncologists and industry executives who spoke at the Damon Runyon

Posted in - Biotech, - Pharma, Harvard, Oncology | Leave a comment

Benjamin Sommers, MD PhD: Expansion of Medicaid and impact on mortality rates

September 7, 2012

Posted in CMS, Harvard | Leave a comment

Paul Richardson, MD: Three-drug regimen for multiple myeloma

December 15, 2015 Dr. Paul Richardson of Harvard’s Dana-Farber Cancer Institute reviews the recent Lancet article

Posted in - Biotech, - Pharma, Harvard, Oncology | Leave a comment

Paul Richardson, MD: Current Therapies for Multiple Myeloma

December 15, 2015- Interviewed by Steven Greer, MD Dr. Paul Richardson, Clinical Director of the Multiple Myeloma Center at Harvard’s Dana-Farber

Posted in - Biotech, - Pharma, Harvard, Oncology | Leave a comment

Benjamin Sommers, MD PhD: the challenges of expanding Medicaid

November 23, 2010- Interviewed by Steven Greer, MD Under the ACA health insurance reform laws, approximately 16 million new Medicaid patients

Posted in CMS, Harvard | Leave a comment

Will more Medicaid patients stress the system financially?

November 23, 2010- Interviewed by Steven Greer MD Under the ACA health insurance reform laws, approximately 16 million new Medicaid patients

Posted in - Opinion, CMS, Harvard | Leave a comment

Early palliative care improves outcomes in lung cancer patients

August 30, 2010- Produced and interviewed by Steven Greer, MD A group from Harvard published a paper in The NEJM that showed early initiation of palliative

Posted in Harvard, Oncology | Leave a comment

Will healthcare spending really continue at its current pace?

December 9, 2009- Interviewed by Steven Greer, MD The consensus among government budget forecasters such as the CBO is that the current growth

Posted in CMS, Harvard | Leave a comment